how many americans are taking glp 1 drugs KFF Health Tracking Poll May 2024: The Public's Use and Views of GLP-1 Here's how many Americans say

Piccinelli M, Wilkinson G

Although not FDA-approved for non-diabetic use, many studies have shown semaglutide's effectiveness in non-diabetics seeking weight loss

112 However, in recent years, the FDA has introduced the patient-focused drug development initiative, where patient-reported outcomes such as improvements in quality of life and healthy life years in MASH patients following treatment can serve as trial endpoints, potentially influencing final approval based on these data

Bielka W, Przezak A, Moleda P, Pius-Sadowska E, Machalinski B

Food and Drug Administration (FDA)-approved to help people manage diabetes and, in some cases, obesity and sleep apnea

Tirzepatide hasnt been compared to the higher dose of semaglutide (Wegovy) now available